Smith & Nephew PLC | |
Stock Exchange | Other OTC |
EPS |
$0.76 |
Market Cap |
$18.79 B |
Shares Outstanding |
874.35 M |
Public Float |
- |
Smith & Nephew PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR0.64 |
Market Cap |
EUR16.99 B |
Shares Outstanding |
874.4 M |
Public Float |
- |
Smith & Nephew PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.61 |
Market Cap |
GBP12.14 B |
Shares Outstanding |
874.4 M |
Public Float |
860.03 M |
Smith & Nephew PLC ADR | |
Stock Exchange | New York Stock Exchange |
EPS |
$1.51 |
Market Cap |
$18.85 B |
Shares Outstanding |
437.38 M |
Public Float |
- |
Address |
Croxley Park Watford Herefordshire WD18 8YE United Kingdom |
Employees | - |
Website | http://smith-nephew.com/ |
Updated | 07/08/2019 |
Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. It operates through the United Kingdom, United States of America, and Other geographical segments. |